TrialDiabetes technology & therapeutics2018

A Randomized Clinical Trial of the Effect of Continuous Glucose Monitoring on Nocturnal Hypoglycemia, Daytime Hypoglycemia, Glycemic Variability, and Hypoglycemia Confidence in Persons with Type 1 Diabetes Treated with Multiple Daily Insulin Injections (GOLD-3).

Arndís F Ólafsdóttir et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.